In prostate cancer patients, high expression of CB1 has been associated with a worse prognosis [6,7], and several authors reported CB1-mediated anti-proliferative and anti-invasive effects of cannabinoids in prostate cancer cells [8,9,10,11,12]. Here, CNR1 is linked to prostate carcinoma.